US Stock MarketDetailed Quotes

BCDA BioCardia

Watchlist

3.050
+0.630+26.03%

Close Apr 29 16:00 ET

3.060
+0.010+0.33%

Post 19:43 ET

14.27MMarket Cap-1.05P/E (TTM)

BioCardia Stock Forum

Jaguar8

Yesterday 06:59

Form 4 insider buy

$BioCardia (BCDA.US)$

Stock_Drift

Apr 28 22:47

Low Floats. 10:46am 4/28

$Locafy (LCFY.US)$ $Golden Heaven (GDHG.US)$ $Medicus Pharma (MDCX.US)$ $Farmmi (FAMI.US)$ $Vicarious Surgical (RBOT.US)$ $DevvStream (DEVS.US)$ $Bon Natural Life (BON.US)$ $Professional Diversity Network (IPDN.US)$ $Autonomix Medical (AMIX.US)$ $Mainz Biomed (MYNZ.US)$ $BioCardia (BCDA.US)$ $Galmed Pharmaceuticals (GLMD.US)$ $INNEOVA Holdings (INEO.US)$

Trytosaveabit

Apr 26 18:12

Lotsa insider buying! New Form 4’s ( Code P )

$BioCardia (BCDA.US)$ Along with these buys! President and CEO Peter Altman has made 10 other open market buys since 12/26/2024!

Jaguar8

Apr 15 21:18

NEWS

$BioCardia (BCDA.US)$
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
Tuesday, 15th April at 8:30 am
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group.
The company plans to progress the trial to enrollment of 39 participants in the United States.
SUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE...

Teddy123

Apr 15 20:40

BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial

$BioCardia (BCDA.US)$
Major Safety Milestone: Revolutionary Heart Failure Cell Therapy Advances to Next Phase

Teddy123

Apr 11 21:24

BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study

$BioCardia (BCDA.US)$
Major Breakthrough: Emory Joins Phase III Trial for Revolutionary Heart Failure Treatment

Jaguar8

Apr 11 21:15

NEWS

$BioCardia (BCDA.US)$
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
Friday, 11th April at 9:15 am
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction and Elevated Markers of Cardiac Stress
Dr. Arshed Quyyumi, Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University School of Medicine, and Co-Directo...

Stock_Drift

Apr 5 02:02

Low Floats. 4/4/25 2:01pm

$Zoomcar Holdings (ZCAR.US)$ $BioCardia (BCDA.US)$ $Golden Heaven (GDHG.US)$ $Forward Industries (FORD.US)$ $Tenax Therapeutics (TENX.US)$ $CERo Therapeutics (CERO.US)$ $Hong Kong Pharma Digital Technology (HKPD.US)$ $Shuttle Pharmaceuticals (SHPH.US)$ $Brera Holdings (BREA.US)$ $Newton Golf (NWTG.US)$ $Universe Pharmaceuticals (UPC.US)$ $iCoreConnect (ICCT.US)$ $Wellchange (WCT.US)$ $Antelope Enterprise (AEHL.US)$ $American Rebel (AREB.US)$

Jaguar8

Apr 1 05:46

🟢Watchlist, APRIL 1,2025, Tuesday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...

71127236

Mar 31 21:50

$BioCardia (BCDA.US)$ overall good news, not as much action as people expected and are selling off. the selling will slow and people that understand the significance will start coming in